Page 1099 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1099
2 References
27. Gregg CR, Nassar NN. Infectious Enteritis. Curr Treat Options responsible for a nosocomial outbreak of Clostridium difficile-
Gastroenterol. 1999;2(2):119-126. associated diarrhea. J Clin Microbiol. 2000;38(7):2706-2714.
28. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice 39. Tabibian N. Diarrhea in critically ill patients. Am Fam Physician.
guidelines for Clostridium difficile infection in adults: 2010 1989;40(2):135-140.
update by the society for healthcare epidemiology of America 40. George WL, Rolfe RD, Harding GK, Klein R, Putnam CW,
(SHEA) and the infectious diseases society of America (IDSA). Finegold SM. Clostridium difficile and cytotoxin in feces of
Infect Control Hosp Epidemiol. 31(5):431-455. patients with antimicrobial agent-associated pseudomembra-
29. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs nous colitis. Infection. 1982;10(4):205-208.
and mortality associated with nosocomial diarrhea due to 41. Schmidt ML, Gilligan PH. Clostridium difficile test-
Clostridium difficile. Clin Infect Dis. 2002;34(3):346-353. ing algorithms: what is practical and feasible? Anaerobe.
30. O’Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging 2009;15(6):270-273.
infectious challenge of clostridium difficile-associated dis- 42. Reller ME, Lema CA, Perl TM, et al. Yield of stool culture with
ease in Massachusetts hospitals: clinical and economic conse- isolate toxin testing versus a two-step algorithm including stool
quences. Infect Control Hosp Epidemiol. 2007;28(11):1219-1227. toxin testing for detection of toxigenic Clostridium difficile.
31. Leclair MA, Allard C, Lesur O, Pepin J. Clostridium difficile J Clin Microbiol. 2007;45(11):3601-3605.
infection in the intensive care unit. J Intensive Care Med. 43. Teasley DG, Gerding DN, Olson MM, et al. Prospective
25(1):23-30. randomised trial of metronidazole versus vancomycin for
32. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, Clostridium-difficile-associated diarrhoea and colitis. Lancet.
toxin gene-variant strain of Clostridium difficile. N Engl J Med. 1983;2(8358):1043-1046.
2005;353(23):2433-2441. 44. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A com-
33. Labbe AC, Poirier L, Maccannell D, et al. Clostridium difficile parison of vancomycin and metronidazole for the treatment of
infections in a Canadian tertiary care hospital before and dur- Clostridium difficile-associated diarrhea, stratified by disease
ing a regional epidemic associated with the BI/NAP1/027 strain. severity. Clin Infect Dis. 2007;45(3):302-307.
Antimicrob Agents Chemother. 2008;52(9):3180-3187. 45. Friedenberg F, Fernandez A, Kaul V, Niami P, Levine GM.
34. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial Intravenous metronidazole for the treatment of Clostridium
acquisition of Clostridium difficile infection. N Engl J Med. difficile colitis. Dis Colon Rectum. 2001;44(8):1176-1180.
1989;320(4):204-210. 46. Fekety R. Guidelines for the diagnosis and management of
35. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Clostridium difficile-associated diarrhea and colitis. American
Melvin ZA, Karchmer AW. Clostridium difficile coloniza- College of Gastroenterology, Practice Parameters Committee.
tion and diarrhea at a tertiary care hospital. Clin Infect Dis. Am J Gastroenterol. 1997;92(5):739-750.
1994;18(2):181-187. 47. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea.
36. Vaishnavi C. Established and potential risk factors for Clostridum N Engl J Med. 2002;346(5):334-339.
difficile infection. Indian J Med Microbiol. 2009;27(4):289-300. 48. Pillai A, Nelson R. Probiotics for treatment of Clostridium
37. Poxton IR, McCoubrey J, Blair G. The pathogenicity of difficile-associated colitis in adults. Cochrane Database Syst Rev.
Clostridium difficile. Clin Microbiol Infect. 2001;7(8):421-427. 2008(1):CD004611.
38. Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin 49. Morrow LE. Probiotics in the intensive care unit. Curr Opin Crit
A-negative, toxin B-positive strain of Clostridium difficile Care. 2009;15(2):144-148.
Section05-O-ref.indd 2 1/20/2015 4:51:24 PM

